newsfilter
← Latest News
GlobeNewswire·

Agios Reports Third Quarter 2026 Financial Results and Provides Business Update

Mitapivat (PYRUKYND® and AQVESME®) delivered worldwide net revenues of $55.4 million in third quarter of 2026, more than four times the $12.9 million reported in third quarter of 2025Strong U.S. demand for AQVESME in